UK pharma industry risks losing world-leading status as investment plummets
A new report by the BPI outlines an alarming drop in British life sciences investment as companies increasingly turn elsewhere.
Investment
European biotechs must understand US culture while seeking funding
How can pharma manage rising trial costs?
Funding drought: how can biotech and biopharma keep trials running?
M&A market performance suffered in Q3 2023
Baltic-bound: is Lithuania desirable for EU life science investment?
Need for more effective and tolerable treatments in diabetic neuropathic pain
Deciding a business location: Why invest in Łódź?
